Protein kinase C activators stimulate beta-endorphin secretion from hypothalamic cells

Relatively little is known about the regulation of secretion of hypothalamic beta-endorphin, the potent opioid that is believed to play a variety of physiological roles in brain. Previous work has shown that arginine vasopressin (AVP), which acts in brain primarily via activation of the phosphoinosi...

Full description

Saved in:
Bibliographic Details
Published inBrain research bulletin Vol. 29; no. 5; p. 553
Main Authors Kapcala, L P, Weng, C F, Juang, H H
Format Journal Article
LanguageEnglish
Published United States 01.11.1992
Subjects
Angiotensin II - pharmacology
Animals
Arginine Vasopressin - pharmacology
beta-Endorphin - metabolism
Colforsin - pharmacology
Diglycerides - pharmacology
Enzyme Activation
Female
Hypothalamus - cytology
Hypothalamus - metabolism
Neural Pathways - cytology
Neural Pathways - drug effects
Pregnancy
Protein Kinase C - metabolism
Radioimmunoassay
Rats
Rats, Sprague-Dawley
Second Messenger Systems - drug effects
Tetradecanoylphorbol Acetate - pharmacology
Online AccessGet more information

Cover

More Information
Summary:Relatively little is known about the regulation of secretion of hypothalamic beta-endorphin, the potent opioid that is believed to play a variety of physiological roles in brain. Previous work has shown that arginine vasopressin (AVP), which acts in brain primarily via activation of the phosphoinositol (PI) second messenger system, stimulates secretion of hypothalamic beta-endorphin. To test the hypothesis that activators of protein kinase C (PKC), which is activated following PI hydrolysis, stimulates secretion of beta-endorphins from hypothalamus, we studied the separate effects of stimulators of PKC including phorbol ester 12-myristate-13-acetate (PMA) and 1-oleolyl-2-acetyl glycerol (OAG- a diacyl glycerol analogue) on secretion of immunoreactive (IR-) beta-endorphin (measured by RIA) from dissociated fetal rat hypothalamic cell cultures. We also studied AVP and angiotensin II (Ang II), hypothalamic peptides which activate the PI second messenger pathway, and interactions of PMA and forskolin (FSK), an activator of the cyclic AMP/protein kinase A (PKA) pathway. PMA, OAG, AVP, and Ang II stimulated IR-beta-endorphin secretion. The stimulatory effect of both PMA and FSK on IR-beta-endorphin secretion was greater than that of PMA or FSK alone and was essentially additive.
ISSN:0361-9230
DOI:10.1016/0361-9230(92)90122-E